Abstract. Nuclear factor erythroid-2-related factor-2 (Nrf2 or NFE2L2) is a master regulator of the anti-oxidative stress response, which is involved in the defense against many oxidative stress/ inflammation-mediated diseases, including anticancer effects elicited by an increasing number of natural products. Our previous studies showed that the epigenetic modification of the Nrf2 gene plays a key role in restoring the expression of Nrf2. In this study, we aimed to investigate the epigenetic regulation of Nrf2 by astaxanthin (AST) and fucoxanthin (FX), carotenoids which are abundant in microalgae and seaweeds, in mouse skin epidermal JB6 P+ cells. FX induced the anti-oxidant response element (ARE)-luciferase and upregulated the mRNA and protein levels of Nrf2 and Nrf2 downstream genes in HepG2-C8 cells overexpressing the ARE-luciferase reporter. Both FX and AST decreased colony formation in 12-Otetradecanoylphorbol-13-acetate (TPA)-induced transformation of JB6 P+ cells. FX decreased the methylation of the Nrf2 promoter region in the JB6 P+ cells by the bisulfite conversion and pyrosequencing. Both FX and AST significantly reduced DNA methyltransferase (DNMT) activity but did not affect histone deacetylase (HDAC) activity in JB6 P+ cells. In summary, our results show that FX activates the Nrf2 signaling pathway, induces the epigenetic demethylation of CpG sites in Nrf2 and blocks the TPA-induced transformation of JB6 P+ cells, indicating the potential health-promoting effects of FX in skin cancer prevention.
INTRODUCTION
The skin, as the outermost layer of the body, is constantly exposed to ultraviolet B (UVB) irradiation and other environmental pollutants. Due to increased exposure to these pollutants, the incidence of skin cancer is steadily increasing worldwide (1) (2) (3) . In the USA, non-melanoma skin cancer is the most common type of cancer, with more than 1 million new cases per year. Natural phytochemicals have been widely used as potential chemopreventive agents against skin cancers (4) (5) (6) . Earlier studies suggest that phytochemical supplements, including curcumin (7), green tea (8) , and ursolic acid (9) , are effective in blocking both chemicalinduced and UVB-induced skin carcinogenesis. However, the exact mechanisms by which these chemopreventive agents shift the balance from reactive intermediates to protective mechanisms by promoting detoxification and radical scavenging reactions remain unclear (10, 11) .
Epigenomic alterations, including DNA methylation, histone modification, and miRNAs, are associated with skin cancer development. These alterations could be useful biomarkers and novel therapeutic targets for the prevention and treatment of skin cancer. For example, drugs that target histone deacetylases (HDACs) and DNA methyltransferase (DNMT) inhibitors have been approved by the FDA as chemotherapeutics, although their toxicity limits their applications (12, 13) . Aberrant epigenetic alterations have been observed in the initiation and progression of skin cancers (14) (15) (16) (17) . Certain dietary phytochemicals that possess chemopreventive effects have been reported to prevent cancer by targeting epigenetic modifications (18, 19) . For example, sulforaphane and phenethyl isothiocyanate, which are derived from cruciferous vegetables and allyl compounds in garlic, have been reported to be potent inhibitors of HDACs and DNMTs (20) (21) (22) (23) (24) .
In addition, increasing evidence indicates that oxidative stress and chronic inflammatory disorders contribute to the increased risk of many diseases, including skin cancers (26) (27) (28) . The nuclear factor erythroid-2-related factor-2 (Nrf2)-anti-oxidant response element (ARE)-mediated antioxidative stress and anti-inflammatory pathways appear to play a major role in protection against carcinogenesis (29, 30) . Nrf2, which is also termed NFE2L2, is a basic-region leucine zipper (bZIP) transcription factor that regulates the expression of many phase II detoxifying enzymes, including glutathione S-transferases (GSTs). Thus, Nrf2 protects against oxidative stress and electrophilic challenges to maintain cellular chemical homeostasis (31) . In the cytosol, Nrf2 binds to Kelch-like ECH-associating protein (Keap1), a substrate adaptor protein for a CUL3-containing E3 ubiquitin ligase (32) . In vivo studies have shown that Nrf2-deficient mice exhibit significantly lower levels of cellular defense in various tissues, as summarized in reviews (33, 34) , with an increased risk of developing carcinogen-induced colorectal (35) and skin cancers (5, (36) (37) (38) . Early studies have reported that sulforaphane's role in phase II enzyme is inducing activities and disruption of the Nrf2-keap1 interaction (39) . However, recent reports have identified effects of sulforaphane on DNA methylation of the Nrf2 gene promoter, HDACs and DNMTs (25) .
Fucoxanthin (FX) and astaxanthin (AST) are two major xanthophyll carotenoids (Fig. 1) . FX has strong anti-oxidant properties against obesity and inflammation (40) (41) (42) . FX reduces the levels of reactive oxygen species (ROS), damage and apoptosis (43) . FX increases the level of glutathione (GSH) by inducing glutamate-cysteine ligase catalytic subunit (GCLC) and glutathione synthetase (GSS) expression via the Akt/Nrf2 pathway in human keratinocytes cells (44) . Recent reports have shown the protective effects of FX against UVBinduced photoaging and sunburn on the skin in vivo (45, 46) . Another important xanthophyll, AST, is well known to have anti-oxidative activities (47) (48) (49) (50) , antitumor effects (51-53), hepatoprotective effects (54), anti-diabetic effects (55) , and anti-inflammatory properties (56) . Both in vivo and in vitro studies suggest that AST has health-promoting activities and could potentially be used for the prevention of various diseases, including cancers (57) and Parkinson's disease (58) . AST and its analog AST esters show protective effects against UVB-7,12-dimethylbenz(a)anthracene (DMBA)-induced skin cancer in rats (59) . We have previously reported that AST shows synergistic anti-oxidant effects with polyunsaturated fatty acids (PUFAs) at low concentrations via the Nrf2/ARE pathway (60) and that AST decreased the methylation of the glutathione S-transferase P (GSTP1) gene (61) . Recently, it has been reported that AST increases chromosomal stability and normalizes epigenetic modifications in oocyte maturation (62) . AST inhibited HDAC-9 expression and facilitated the inactivation of hepatic stellate cells, which are critical for liver fibrosis development (63) .
However, the effects of FX and AST on the reversal of abnormal epigenetic changes have not yet been clearly described in skin cells. The JB6 P+ is a promotion-sensitive and post-initiated mouse epidermal cell line, an in vitro cell model for tumor promotion induced by tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and epidermal growth factor (64, 65) . Human hepatoma HepG2 cells have been used as the model cell line for the study of phase II enzyme induction (66) . We hypothesize that two important xanthophylls, FX and AST, inhibit the neoplastic transformation of mouse skin JB6 P+ cells induced by TPA. The molecular mechanism may be mediated by the activation of Nrf2-mediated pathways and epigenetic modification by 
Cell Culture and Treatment
The human hepatocellular HepG2-C8 cell line was previously established by stable transfection with the pARE-TI-luciferase construct (provided by Dr. William Fahl, University of Wisconsin). Both the HepG2 immortalized human hepatoma cell line and mouse epidermal JB6 P+ cells were purchased from American Type Culture Collection. The HepG2-C8 cells were maintained in DMEM supplemented with 10% FBS. The JB6 P+ cells were maintained in MEM with 5% FBS. JB6 P+ cells stably transfected with shMockand shNrf2-knockdown were established using virusmediated short hairpin RNAs (shRNAs) maintained in MEM supplemented with 5% FBS and 2 μg/mL puromycin as previous described (25) . Cells were treated with various concentrations of FX, AST or 5-aza in combination with TSA. The medium was changed every 2 days. One hundred nanometer TSA was added to the medium with the 5-aza at 500 nM for another 18 h before the cell harvest. All cells were maintained in the cell culture medium, which was supplemented with 10 U/mL penicillin G and 100 μg/mL streptomycin at 37°C in a humidified 5% CO 2 atmosphere. FX and AST were dissolved in DMSO. DMSO was used as a vehicle in all experiments at a concentration of 0.1%.
Cell Viability Test-MTS Assay
The JB6 P+ cells were seeded in a 96-well plate at a density of 5 × 10 3 cells/well for 24 h and were treated with DMSO 0.1%, FX, or AST at various concentrations for 1, 3, or 5 days. The cell culture medium was changed every other day. The HepG2-C8 cells were seeded in a 96-well plate at a density of 1 × 10 4 cells/well for 24 h and then were treated with either DMSO 0.1% or various concentrations of FX for 24 h in DMEM supplemented with 1% FBS. To determine cell viability, the CellTiter® 96 aqueous non-radioactive cell proliferation assay (Promega, Madison, WI, USA) was used according to the manufacturer's instructions.
Luciferase Reporter Activity Assay
Stably transfected HepG2-C8 cells were used to study the effects of FX on the Nrf2-ARE pathway. The HepG2-C8 cells were seeded at a density of 1 × 10 5 cells/well in 12-well plates for 24 h. The cells were treated with vehicle or various concentrations of FX in DMEM supplemented with 1% FBS for 24 h. ARE-luciferase activity was determined using the luciferase activity assay kit (Promega, Madison, WI, USA) according to the manufacturer's instructions. The cells were lysed by the reporter lysis buffer in each well, and 10 μl of the cell lysate supernatant were analyzed for Nrf2-ARE activity using a Sirius luminometer (Berthold Detection System GmbH, Pforzheim, Germany). The results were normalized against the protein concentration in each sample as determined by a BCA protein assay (Pierce Biotech, Rockford, IL, USA). The results are expressed as an inducible fold change compared with the vehicle control (0.1% DMSO) from three independent replicates.
RNA Extraction and Quantitative Real-time Polymerase Chain Reaction
HepG2-C8 cells were seeded in 6-well plates at a density of 3 × 10 5 cells/well and then treated with vehicle or FX at various concentrations for another 6 h. JB6 P+ cells were seeded in 6-well plates at a density of 1 × 10 4 cells/dish for 3, 6, or 24 h and then treated with the vehicle control, FX, or AST at various concentrations for 3 days or as indicated in the figures. Total RNA was extracted using an RNeasy Micro Kit (Qiagen, Valencia, CA, USA), according to the manufacturer's protocol. In total, 1 μg of RNA from each sample was used to synthesize the first-strand cDNA by the SuperScript III First-Strand cDNA Synthesis System (Invitrogen, Grand Island, NY, USA). The mRNA expression of Nrf2 and the Nrf2 downstream genes was determined using the Applied Biosystems 7900HT Fast Real-Time PCR System and compared with the vehicle control (0.1% DMSO). The primer pairs used were as previously described (25, 67) .
Preparation of Protein Lysis and Western Blotting
The protein concentrations of the cleared lysates were determined using the BCA method (Pierce, Rockford, IL); 25 μg of the total protein was resolved by 4 to 15% SDS-PAGE (Bio-Rad, Hercules, CA). After electrophoresis, the proteins were electrotransferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA). The PVDF membrane was then blocked with 5% BSA in PBS-0.1% Tween 20 and then sequentially incubated with specific primary antibodies and horseradish peroxidase (HRP)-conjugated secondary antibodies. The blots were visualized by the super signal enhanced chemiluminescence detection system and documented using the Gel Documentation 2000 system (Bio-Rad, Hercules, CA). The anti-Nrf2, anti-NQO1, anti-HO1, anti-SOD, and anti-β-ACTIN antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Anchorage-Independent Cell Neoplastic Transformation Assay
JB6 P+ cells were used in the TPA-induced neoplastic transformation assay as previously described (25, 68) . Cells were transferred to 1 mL of Basal Medium Eagle medium with 0.33% agar over 3 mL of BME medium with 0.5% agar supplemented with 10% FBS in 6-well plates. These cells were treated with 0.1% DMSO, TPA (20 ng/mL) alone, or TPA in combination with FX or AST. The colonies formed from the transformed cells were photographed using a computerized microscope system with the Nikon ACT-1 program (Version 2.20, LEAD Technologies, Charlotte, NC) and counted using the ImageJ program (Version 1.40 g, National Institutes of Health).
DNA Extraction and Pyrosequencing
Genomic DNA was isolated from the treated JB6 P+ cells using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA). The bisulfite conversion of the genomic DNA was performed using the EZ DNA Methylation Gold Kit (Zymo Research Corp, Irvine, CA) according to the manufacturer's instructions as previously described (69) . The converted DNA was amplified by PCR using the Platinum PCR SuperMix (Invitrogen, Carlsbad, CA) with primers designed for the Nrf2 gene promoter region that spanned the methylated CpG sites from − 1226 to − 1069, with the translational start site (TSS) referenced as + 1, as previously described (70) . The sequences of the primers were 5′-AGTAGTAAAAATATTTTTTTAGTTGGAGGT-3′ (sense), 5′ ATATAATCTCATAAAACCCCACCTCT-3′ (antisense), and ATTTTTTTAGTTGGAGGTTATT (sequencing). The following PCR amplification conditions were used: 3 min at 94°C, 30 s at 94°C, 45 s at 70/55°C, and 1 min at 72°C for 15 cycles; 30 s at 94°C, 45 s at 60°C, and 1 min at 72°C for 25 cycles; and 5 min at 72°C for 1 cycle. The pyrosequencing was then carried out on the PCR products with a PyroMark Q 96 ID Sequencer from Qiagen (Valencia, CA, USA) using the pyrosequencing primers, enzymes and substrate (PyroMark Gold®Q96 Reagents kit, Qiagen, CA, USA) per the manufacturer's protocol.
DNMT and HDAC Activity Assays
The DNMT activity and HDAC activity assays were conducted using a DNMT Activity/Inhibition Assay Kit Fig. 3 . Inhibitory effects of AST and FX on the anchorageindependent colony formation of JB6 P+ cells. The colonies that exhibited anchorage-independent growth were counted under a microscope using ImageJ software. a Representative images under a microscope; b The graphical data are presented as the means ± SEM of three independent replicates. **, P < 0.01 and ***, P < 0.001, indicate significant differences between the treatment groups and TPA alone. Student's t test was used to calculate the significance of the differences (Epigentek, Farmingdale, NY) and an HDAC Activity/ Inhibition Direct Assay Kit (Epigentek, Farmingdale, NY), respectively, following the manufacturer's protocols. The nuclear protein fraction was extracted using the NEPER Nuclear and Cytoplasmic Protein Extraction Kit (Thermo Scientific, Pittsburgh, PA), and the relative DNMT activity was calculated based on the ratio of the treatment group to the control group after the normalization to the amount of protein.
Data Presentation and Statistical Analysis
At least three independent experiments were performed for each analysis. The results are presented as the mean ± standard error of the mean (SEM) of each group unless otherwise specified. The differences between the controls and the treated groups were evaluated using Student's t tests. Significance includes *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
RESULTS

Cytotoxicity of FX and AST in JB6 P+ Cells
The cell viability of the JB6 P+ cells was measured by the MTS assay as shown in Fig. 2 . The JB6 P+ cells were treated with various concentrations of FX or AST for 1, 3, or 5 days to examine their cytotoxicity. Treatment with AST or FX showed time-and dose-dependent effects on the cell viability (Fig. 2) . The cell viability of JB6 P+ cells that were treated with 50 μM of AST was 91.4% after the 5-day treatment, which was much higher than the 23.5% cell viability after the 5-day treatment with 50 μM of FX. The cell viabilities following the AST (< 50 μM) and the FX (< 12.5 μM) treatments were greater than 50% after the 1-, 3-, and 5-day treatments. These doses were used in the subsequent studies.
FX and AST Inhibit the TPA-Induced Cell Transformation of JB6 P+ Cells
The effects of FX and AST treatment on the TPAinduced anchorage-independent growth of the JB6 P+ cells were examined in soft agar following a 14-day treatment (Fig. 3) . Compared with the TPA treatment alone, the FX and AST treatment, at various concentrations ranging from 6.25 to 25 μM, significantly decreased the number of JB6 P+ transformed cell colonies in Fig. 3 . Representative figures were selected from three independent replicates and showed that the number and size of the JB6 P+ transformed cell colonies are smaller than those in the group treated with TPA alone in Fig. 3a . Both FX and AST, at the selected doses, inhibited the TPA-induced JB6 P+ cell transformation with a relatively low toxicity, suggesting their potential to protect JB6 P+ cells against TPA-induced carcinogenesis.
FX Induces ARE-Luciferase Reporter Activity in HepG2-C8 Cells
To investigate the mechanism underlying these effects, we used HepG2-C8 cells that were stably transfected with the ARE-luciferase reporter vector. We have previously reported that AST, in concentrations ranging from 12.5 to 100 μM, significantly induced luciferase activity with a relatively low toxicity (60) . In this study, HepG2-C8 cells were treated with 100 μM of FX for 24 h, and the cell viability was approximately 70% compared with that of the vehicle control, which was treated with 0.1% DMSO (Fig. 4a) . By comparing the cell viability of the FX-treated HepG2 cells with that of the JB6 P+ cells, it seems that the HepG2 cells are more resistant to the treatment toxicity of FX. FX significantly induced luciferase activity in a dose-dependent manner at concentrations ranging from 25 to 100 μM (Fig. 4b) . However, 3.13 to 12.5 μM of FX did not significantly induce luciferase activity. Fig. 4 . Cell viability and induction of ARE-luciferase activity by FX treatment in HepG2-C8 cells transfected with the ARE-luciferase vector. a Cell viability of the JB6 P+ cells after treatment with FX. Cells were treated with various concentrations of FX ranging from 3.13 to 100 μM for 1 day. Cell viability was determined by the MTS assay. The data are presented as the means ± SEM. b The luciferase activity was normalized based on the protein concentrations in the BCA protein assay. The data are presented as the means ± SEM of three independent experiments. **, P < 0.01 and ***, P < 0.001 indicate significant differences between the treatment groups and the control group (DMSO 0.1% without FX). Student's t test was used to calculate the significance of the differences compared with the control
FX Increases the mRNA and Protein Expression Levels of Nrf2 and Downstream Genes in HepG2-C8 Cells
FX treatment increased the mRNA expression of Nrf2 (NFE2L2) at 50 μM significantly and SOD at dose-dependent manner in the HepG2-C8 cells. The mRNA expression levels of HO-1 and NQO1 were increased by FX treatment in a dose-dependent manner, but the increases were not significant (Fig. 5a) . The protein levels of Nrf2, NQO1, HO-1, and SOD were further evaluated in HepG2-C8 cells with various concentrations of FX by western blotting, as shown in Fig. 5b , c. FX, in concentrations ranging from 3.13 to 50 μM, increased the protein expression levels of Nrf2, NQO1, HO-1, and SOD in a concentration-dependent manner. These results suggest that FX has the potential to activate the Nrf2 pathway and, thus, anti-oxidant and detoxifying enzymes in HepG2-C8 cells.
FX Increases the mRNA Expression Levels of Nrf2 and Nqo1
JB6 P+ cells were treated with FX or AST for 3, 6, or 24 h to investigate the dose-response and time course of the mRNA expression of Nrf2 (or Nfe2l2), Nqo1 (Fig. 6a) and Dnmts (Fig. 6b) . As shown in Fig. 6a , 24-h treatment with FX significantly increased the mRNA expression of Nrf2 by 2.8-fold at 12.5 μM (P = 0.012) and 2.0-fold at 25 μM (P = 0.047). Additionally, 25 μM of FX significantly induced the mRNA expression of Nqo1 at all measured time points. Compared with FX, AST significantly increased Nrf2 mRNA expression from 6 h and only decreased its expression at 25 μM with the 24-h treatment. Regarding Student's t test was used to calculate the significance of the differences compared with the control*, P < 0.05 The data are expressed as the means ± SEM of at least three independent replicates. Student's t test was used to calculate the significance of the differences compared with the control, *, P < 0.05, **, P < 0.01, and ***, P < 0.001 Nqo1, there was no significant change, but AST reduced the mRNA expression of Nqo1 by 0.82-fold at 6.25 μM (P = 0.04). FX but not AST significantly induced protein expression of Nrf2 in JB6 P+ cells (Fig. 6d) . In Fig. 6b , FX, at concentrations ranging from 6.25 to 25 μM, significantly reduced the mRNA expression of Dnmt1 after 24 h of treatment. The protein expression of DNMT1 was significantly reduced by the treatment of FX but not AST (Fig. 6c) . However, 12.5 and 25 μM of FX induced the mRNA expression of Dnmt3b after the 24-and 3-h treatments, respectively. AST reduced the mRNA expression of Dnmt3a by 0.81-fold after the 3-h treatment (P = 0.015) and 0.71-fold after the 24-h treatment (P = 0.015). However, AST significantly increased the mRNA expression of Dnmt3b after the 6-h treatment and decreased its expression at 6.25 μM after the 24-h treatment, but no significant changes occurred with the other concentrations.
Knockdown of Nrf2 in TPA-Induced JB6 P+ Cell Transformation in the Treatment of FX and AST The efficiency of shMock and shNrf2 in JB6 P+ cells was examined and the protein expression of Nrf2 was significantly reduced in shNrf2 JB6 P+ cells in Fig. 7a (P < 0.01) . Treatment of FX from 6.25 to 25 μM suppressed the colony number significantly in both shMock and shNrf2 JB6 P+ cells. Compared to FX, the treatment of AST at 25 μM significantly inhibited the TPA-induced anchorage-independent growth of the shMock JB6 P+ cells but not in the shNrf2 JB6 P+ cells. The knockdown of Nrf2 in shNrf2 JB6 P+ cells showed significantly decreased resistance of the cells to TPA-induced cell transformation with the treatment of AST at 25 μM but not FX (Fig. 7b, c) . The protective role of AST at 25 μM in shNrf2 JB6 P+ cells was significantly reduced compared to shMock JB6 P+ cells. These results suggest preventive effects of AST and FX in TPA-induced JB6 P+ cell transformation are not completely dependent on the Nrf2 on TPA-induced JB6 P+ cell transformation.
FX Decreased the Methylated CpG Ratio in the Nrf2 Gene Promoter Region by Pyrosequencing
Furthermore, pyrosequencing was performed to determine the methylation status of the Nrf2 promoter region (Fig. 8) . Hypermethylation in the first five CpG sites was observed, and, on average, 90.1% of these five CpG sites were in the Nrf2 promoter region, which is consistent with Fig. 7 . Inhibitory effects of AST and FX on the anchorageindependent colony formation of shNrf2 and shMock transfected JB6 P+ cells. a Reduced Nrf2 protein expression in shNrf2 JB6 P+ cells with representative figure and quantification from three independent replicates. The colonies that exhibited anchorageindependent growth were counted under a microscope and further analyzed using ImageJ software. b Representative images under a microscope; c The graphical data are presented as the means ± SEM of three independent replicates. **, P < 0.01 and ***, P < 0.001, indicate significant differences between the treatment groups and TPA alone. Student's t test was used to calculate the significance of the differences Fig. 8 . Effects of FX and AST on methylation alteration in the Nrf2 promoter regions in JB6 P+ cells by pyrosequencing. Cells were treated with various concentrations of FX, AST, or 5-aza for 3 days. The medium was changed every 2 days. One hundred nanometer TSA was added to the medium with the 5-aza at 500 nM for another 18 h before the cell harvest. The methylation patterns of the first five CpG sites located at positions − 1226 to − 1086 from the TSS (defined as position 1) in the Nrf2 promoter were determined by pyrosequencing as described in BMATERIALS AND METHODS^. a Methylation of the first five CpG sites from the Nrf2 promoter region. The data are presented as the means ± SEM of at least four independent replicates. *, P < 0.05 and ***, P < 0.001 indicate significant differences between the treatment groups and the control group. Student's t test was used to calculate the significance of the differences compared with the control previous reports. We previously reported that 5-aza, a DNMT inhibitor, and TSA, an HDAC inhibitor, in combination decreased the CpG methylation levels in the Nrf2 gene promoter region in murine prostate cancer TRAMP C1 cells and human prostate cancer LNCaP cells (69, 70) .
HDAC and DNMT Activity Assays
AST (25 μM) significantly reduced the DNMT activity in the JB6 P+ cells after a 3-day treatment (Fig. 9a) ; however, the 3-day AST treatment did not have a significant effect on the HDAC activity (Fig. 9b) . Compared with AST, FX at a low dose of 6.25 μM significantly reduced the DNMT activity by 67.5% (P = 0.0051), but there was no significant change in the HDAC activity.
DISCUSSION
Oxidative stress occurs through free radicals that oxidize nucleic acids, proteins, and lipids, causing a gradual deterioration and leading to degenerative diseases, such as cancer and heart disease (71) . The main characteristic of an antioxidant is its ability to induce enzymes that trap free radicals (72) . Although the biochemical process by which chemoprotective agents protect against cancers that are caused by oxidative stress has not been fully discovered, phase II detoxifying/anti-oxidant enzymes clearly play a role in fighting oxidative stress and preventing cancers (30) . These enzymes detoxify harmful substances by converting them into hydrophilic metabolites that can then be excreted from the human body. Studies have shown that the higher the presence of the phase II detoxifying/anti-oxidant enzymes, such as NAD(P)H, NQO1, GSTM2, HO-1, and SOD, in the tissue, the less susceptible the tissue is to cancers. Nrf2 and its interaction with AREs increase the transcription of these phase II detoxifying/anti-oxidant enzymes (30) . Our present study shows that FX increased the ARE-luciferase activity in HepG2-C8 cells transfected with the ARE-luciferase vector (Fig. 4) and increased the mRNA and protein expression of Nrf2, NQO1, HO-1, and SOD in HepG2-C8 cells. In addition, FX increased the mRNA expression and proteins expression of Nrf2 after 24 h treatment in JB6 P+ cells (Fig. 6) . However, the FX-mediate suppression of TPA-induce transformation is not completely dependent on Nrf2, because there was no significant difference between the shMock and shNrf2 JB6 P+ cells. It is possible that the FX-mediated inhibition in TPAinduced transformation is through other mechanisms including P53-mediated apoptosis and disruption of Nrf2-Keap1 signaling pathway and Nrf2-downstream target genes.
Another possible mechanism by which FX may prevent oxidative stress and, ultimately, cancer is through epigenetic alterations to Nrf2 DNA methylation, which causes changes in gene expression without altering the DNA composition itself. Epigenetic regulation, including DNA methylation and histone modification, is an important process in cancer development. The DNMT enzymes DNMT1, 3a and 3b are directly involved in transferring methyl groups to DNA cytosine. In this study, we observed that both FX and AST Fig. 9 . Effects of FX and AST on the activities of DNMTs and HDACs. JB6 P+ cells were treated with various concentrations of FX and AST for three days. The relative DNMT and HDAC activities were normalized to the protein amount of each group and were calculated based on the ratio of the FX and AST treatment groups to the control group following the manufacturer's protocol. The results of a DNMT activity and b HDAC activity are presented as the means ± SEM. Student's t test was used to calculate the significance of the differences compared with the control. **, P < 0.01 inhibited the activity of DNMTs, but there was no significant difference in the activity of HDACs (Fig. 8) . We found that FX decreased the mRNA and protein expression of DNMT1 significantly, which may be one of the underlying mechanism for the FX-induced demethylation of Nrf2. For the Nrf2 expression, although there was no significant difference on Nrf2 mRNA expression with the treatment of FX at 6.25 μM (Fig. 6a) , the protein expression of Nrf2 was induced by FX at 6.25 μM significantly (Fig. 6d) . In addition, DNMT activity can be modulated by other molecular interactions, posttranslational modifications and alternative splicing as summarized in review (6) . It is possible that FX at higher concentrations may interact with other mechanisms to increase the activity of DNMTs (Fig. 9a) to compensate the reduced DNMT1 protein expression (Fig. 6c) . In our previous study, the epigenetic reactivation of the Nrf2 pathway appeared to be an important mechanism for the inhibition of TPA-induced transformation of JB6 P+ cells (25) . We observed that FX significantly reduced the methylation of the first CpG sites in the Nrf2 promoter region, particularly the fourth CpG site (Fig. 8) , and expression of DNMT1 (Fig. 6c) . Compared with FX, AST did not change the methylation of the CpG sites in the Nrf2 promoter region, but 5-aza+TSA, the positive control, significantly reduced all five CpG sites (Fig. 8) . These data suggest that, although AST and FX share similar structures, their underlying mechanisms of Nrf2 activation differ in their inhibition of the TPA-induced transformation of JB6 P+ cells. Further studies will be necessary to elucidate the effects of FX and AST on the expression and methylation other genes involved in the Nrf2-keap1 signaling pathway.
FX and AST are both novel marine carotenoids with anti-oxidant properties that reduce oxidative stress markers. The protective effects of FX and AST have recently been identified, including the effects of FX against UVB-induced photoaging and sunburn on skin (45, 46) and the effects of AST against UVB-DMBA-induced skin cancer in rats (59) . In a recent clinical report, AST helped reduce oxidative stress and free radical production in athletes and healthy subjects during physical exercise (31) . The health-promoting effects of FX and AST make them highly valuable carotenoids and potential dietary/topical treatments for various diseases; however, their effects and mechanisms in skin cancer prevention remain to be further elucidated.
CONCLUSION
In conclusion, our present study shows that FX activates the Nrf2 pathway, thereby contributing to the inhibition of the TPA-induced transformation of JB6 P+ cells. Furthermore, 6.25 μM of FX significantly decreased the DNMT activity, mRNA expression of Dnmt1 after a 24-h treatment, and methylation of the Nrf2 methylation region. FX and AST activate the Nrf2 pathway, showing a potentially protective role in skin cancer prevention.
